Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Summary: A new educational program is available for doctors and nurses who treat acute myeloid leukemia (AML). It helps healthcare workers create personal treatment plans using the latest DNA testing. The course covers new treatments for both early and returning AML, plus ways to handle medication side effects. It is open from July 2025 to July 2026.

For more details, see rssapp-hcplive-com at gotoper.com/courses/cases-conversations-transforming-aml-careprecision-strategies-evolving-therapies-and-clinical-insights-91pp (opens in new tab)